Similarly, mice receiving 100 μg of a chimeric MUC1 DNA vaccine, encoding the transmembrane- and C-terminal domain-deleted Muc1 gene fused to the human HSP70 gene, had greater anti-tumor effects. This evidence concerns the gene MUC1 and neoplasm.